Microglial roles in Alzheimer's disease: An agent‐based model to elucidate microglial spatiotemporal response to beta‐amyloid
Abstract Alzheimer's disease (AD) is characterized by beta‐amyloid (Aβ) plaques in the brain and widespread neuronal damage. Because of the high drug attrition rates in AD, there is increased interest in characterizing neuroimmune responses to Aβ plaques. In response to AD pathology, microglia...
Main Authors: | Catherine Weathered, Sophia Bardehle, Choya Yoon, Niyanta Kumar, Cheryl E. G. Leyns, Matthew E. Kennedy, Peter Bloomingdale, Elsje Pienaar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.13095 |
Similar Items
-
Microglial amyloid beta clearance is driven by PIEZO1 channels
by: Henna Jäntti, et al.
Published: (2022-06-01) -
Aging and Progression of Beta-Amyloid Pathology in Alzheimer’s Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression
by: Cristina Fernández-Mendívil, et al.
Published: (2020-07-01) -
Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
by: Lin Nan, et al.
Published: (2011-06-01) -
Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
by: Zhiwei Shen, et al.
Published: (2018-10-01) -
VEGF controls microglial phagocytic response to amyloid-β
by: Priscille de Gea, et al.
Published: (2023-12-01)